Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries

The American Journal of Cardiology
Graham S GardnerTIMI Study Group

Abstract

We hypothesized that blood flow in noninfarct arteries would improve after percutaneous coronary intervention of the culprit artery in the setting of ST-elevation myocardial infarction (STEMI). The corrected Thrombolysis In Myocardial Infarction (TIMI) frame count was measured in 94 patients (102 arteries) enrolled in the INTEGRITI, ENTIRE, and FASTER trials of reduced dose fibrinolytic and glycoprotein IIb/IIIa inhibition. The corrected TIMI frame count in nonculprit arteries improved by 3.4 +/- 13.4 frames after percutaneous coronary intervention but remained significantly slower than flow in normal arteries.

References

Feb 17, 2000·Journal of the American College of Cardiology·M MarzilliA L'Abbate
Dec 13, 2000·The American Journal of Cardiology·C M GibsonUNKNOWN Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis
Jul 5, 2002·The New England Journal of Medicine·Antonino BuffonAttilio Maseri

❮ Previous
Next ❯

Citations

Apr 22, 2008·Journal of Thrombosis and Thrombolysis·Vijayalakshmi KunadianC Michael Gibson
Sep 27, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Barry HenniganKeith G Oldroyd
Jan 15, 2011·JACC. Cardiovascular Interventions·C Michael Gibson, Duane Pinto
Jun 26, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Raisuke IijimaMasato Nakamura
Nov 2, 2019·Scandinavian Cardiovascular Journal : SCJ·Ji-Yeoun SeoJoon-Han Shin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.